Economics of Botulinum Toxin Therapy: Influence of the AbobotulinumtoxinA Package Size on the Costs of Botulinum Toxin Therapy
Objective: To explore whether more differentiated package sizes allow for more economic use of Dysport® in a large neurological botulinum toxin (BT) outpatient clinic (>9000…Development of a biomarker for Parkinson’s disease by measuring alpha-synuclein oligomers in cerebrospinal fluid with ultrasonication-induced amyloid fibril formation
Objective: To establish a new technique quantifying misfolded alpha-synuclein (αSyn) oligomers in the CSF and to investigate their clinical - pathological significances in Parkinson’s disease…Is early onset ataxia phenotypically discernible from developmental disorders with impaired coordination?
Objective: To investigate: 1. the diagnostic accuracy of phenotypic Early Onset Ataxia (EOA) recognition among other pediatric disorders with impaired coordination (developmental coordination disorder (DCD)…Transient dystonia of infancy: 25 cases
Objective: Characterize a group of pediatric patients with transient dystonia of infancy. Background: Transient dystonia of infancy is a Developmental and Benign Movement Disorder characterized…Pediatric Tics and DCD: Motor Network Disorders?
Objective: To characterize and quantify pediatric tics and DCD according to specific movement disorder features. Background: Until now, it has been impossible to attribute the…Deep brain stimulation and its efficacy using microelectrode recording
Objective: To render the significance of microelectrode recording and elucidate its prognostic role in response to STNDBS. Background: Studies[1]-[9] have correlated local field potential(LFP) and…Using remotely collected data to identify Parkinson’s disease (PD) subtypes
Objective: To evaluate the possibility of using remotely collected data to allocate newly diagnosed PD patients to phenotypic subgroups, to identify patients suitable for inclusion…The Use of eConsult in a Movement Disorders Clinic
Objective: To assess the use of eConsults in a Movement Disorders clinic. Background: The availability of specialized care in most regions is limited and novel…Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
Objective: The aims of the present study were to profile the expression of microRNA29 family (miR-29s) in blood serum from patients with PD vs unaffected…Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer
Objective: To assess feasibility of developing a CNS LRRK2 PET tracer. Background: LRRK2 enzyme belongs to the leucine-rich repeat kinase family. Pathogenic mutations in the…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- Next Page »